Stefani Spranger
6Patents
1h-index
6Co-inventors
36Inventor score
Filing activity: Aug 1, 2012 → Jun 15, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10034939B2 | Synergistic combination of immunologic inhibitors for the treatment of cancer | Human Necessities | 3 | Active |
| US10753938B2 | Beta-catenin inhibitors in cancer immunotherapy | Physics | 1 | Active |
| US9504692B2 | Selective inhibition of MALT1 protease by phenothiazine derivatives | Chemistry; Metallurgy | 0 | Active |
| US10967060B2 | Synergistic combination of immunologic inhibitors for the treatment of cancer | Human Necessities | 0 | Active |
| US11946936B2 | Beta-catenin inhibitors in cancer immunotherapy | Physics | 0 | Active |
| US12061186B2 | Compositions and methods for using cross-dressing to enhance anti-tumor immune responses | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.